Daito Pharmaceutical to Merge Kyorin's Generic Drugs Into New Venture, Warns of Unprofitable Parkinson's Pill
Daito Pharmaceutical is folding into a new joint venture to absorb Kyorin's generic drug business while telling lawmakers that three straight years of annual price cuts have made its dominant Parkinson's disease tablet impossible to produce at a profit.